{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:16:14Z","timestamp":1791569774322,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,4]]},"DOI":"10.7759\/cureus.61678","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T19:40:49Z","timestamp":1717530049000},"source":"Crossref","is-referenced-by-count":13,"title":["Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Tyler E","family":"Rice-Canetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali J","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie A","family":"Kyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1098734","article-title":"Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: a systematic review and meta-analysis","volume":"14","author":"Khan MI","year":"2023","unstructured":"Khan MI, Qureshi H, Akhtar S, Bae SJ, Hassan F. Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: a systematic review and meta-analysis. Front Psychiatry. 2023, 14:1098734. 10.3389\/fpsyt.2023.1098734","journal-title":"Front Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2020\/e1515","article-title":"Neuropsychiatric lupus erythematosus: future directions and challenges; a systematic review and survey","volume":"75","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Han H, Chu L. Neuropsychiatric lupus erythematosus: future directions and challenges; a systematic review and survey. Clinics (Sao Paulo). 2020, 75:e1515. 10.6061\/clinics\/2020\/e1515","journal-title":"Clinics (Sao Paulo)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08865-2","article-title":"Autoantibodies in neuropsychiatric systemic lupus erythematosus (NPSLE): can they be used as biomarkers for the differential diagnosis of this disease?","volume":"63","author":"Manca E","year":"2022","unstructured":"Manca E. Autoantibodies in neuropsychiatric systemic lupus erythematosus (NPSLE): can they be used as biomarkers for the differential diagnosis of this disease?. Clin Rev Allergy Immunol. 2022, 63:194-209. 10.1007\/s12016-021-08865-2","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102892","article-title":"Neuropsychiatric lupus erythematosus: focusing on autoantibodies","volume":"132","author":"Wang J","year":"2022","unstructured":"Wang J, Xu J, Yang P. Neuropsychiatric lupus erythematosus: focusing on autoantibodies. J Autoimmun. 2022, 132:102892. 10.1016\/j.jaut.2022.102892","journal-title":"J Autoimmun"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102780","article-title":"Neuropsychiatric involvement in systemic lupus erythematosus: a review","volume":"20","author":"Carri\u00f3n-Barber\u00e0 I","year":"2021","unstructured":"Carri\u00f3n-Barber\u00e0 I, Salman-Monte TC, V\u00edlchez-Oya F, Monfort J. Neuropsychiatric involvement in systemic lupus erythematosus: a review. Autoimmun Rev. 2021, 20:102780. 10.1016\/j.autrev.2021.102780","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis A","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, et al.. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024, 83:15-29. 10.1136\/ard-2023-224762","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236825","article-title":"Cerebellar ataxia as a primary manifestation of neuropsychiatric systemic lupus erythematosus","volume":"14","author":"Sy MC","year":"2021","unstructured":"Sy MC, Reyes NG, Zamora GT, Fernandez ML. Cerebellar ataxia as a primary manifestation of neuropsychiatric systemic lupus erythematosus. BMJ Case Rep. 2021, 14:e236825. 10.1136\/bcr-2020-236825","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152250","article-title":"Long-term outcome of status epilepticus-related to systemic lupus erythematosus: an observational study and a systematic review","volume":"63","author":"Mikdashi J","year":"2023","unstructured":"Mikdashi J, Krumholz A. Long-term outcome of status epilepticus-related to systemic lupus erythematosus: an observational study and a systematic review. Semin Arthritis Rheum. 2023, 63:152250. 10.1016\/j.semarthrit.2023.152250","journal-title":"Semin Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2021.02.021","article-title":"Seizures in systemic lupus erythematosus: a scoping review","volume":"86","author":"Rodriguez-Hernandez A","year":"2021","unstructured":"Rodriguez-Hernandez A, Ortiz-Orendain J, Alvarez-Palazuelos LE, Gonzalez-Lopez L, Gamez-Nava JI, Zavala-Cerna MG. Seizures in systemic lupus erythematosus: a scoping review. Seizure. 2021, 86:161-7. 10.1016\/j.seizure.2021.02.021","journal-title":"Seizure"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102996","article-title":"Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"21","author":"Wang M","year":"2022","unstructured":"Wang M, Wang Z, Zhang S, et al.. Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev. 2022, 21:102996. 10.1016\/j.autrev.2021.102996","journal-title":"Autoimmun Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.02.007","article-title":"What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis","volume":"48","author":"Rayes HA","year":"2018","unstructured":"Rayes HA, Tani C, Kwan A, et al.. What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum. 2018, 48:240-55. 10.1016\/j.semarthrit.2018.02.007","journal-title":"Semin Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102911","article-title":"Cognitive dysfunction in SLE: an understudied clinical manifestation","volume":"132","author":"Mizrachi M","year":"2022","unstructured":"Mizrachi M, Anderson E, Carroll KR, Tehrani N, Volpe BT, Diamond B. Cognitive dysfunction in SLE: an understudied clinical manifestation. J Autoimmun. 2022, 132:102911. 10.1016\/j.jaut.2022.102911","journal-title":"J Autoimmun"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.08.002","article-title":"Altered functional neuronal activity in neuropsychiatric lupus: a systematic review of the fMRI investigations","volume":"45","author":"Mikdashi JA","year":"2016","unstructured":"Mikdashi JA. Altered functional neuronal activity in neuropsychiatric lupus: a systematic review of the fMRI investigations. Semin Arthritis Rheum. 2016, 45:455-62. 10.1016\/j.semarthrit.2015.08.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211025636","article-title":"Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: a systematic review and results from the Swiss lupus cohort study","volume":"30","author":"Meier AL","year":"2021","unstructured":"Meier AL, Bodmer NS, Wirth C, et al.. Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: a systematic review and results from the Swiss lupus cohort study. Lupus. 2021, 30:1565-76. 10.1177\/09612033211025636","journal-title":"Lupus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320948181","article-title":"Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: a systematic review","volume":"29","author":"Constantin A","year":"2020","unstructured":"Constantin A, N\u0103stase D, Tulb\u0103 D, B\u0103l\u0103nescu P, B\u0103icu\u0219 C. Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: a systematic review. Lupus. 2020, 29:1509-19. 10.1177\/0961203320948181","journal-title":"Lupus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-023-10075-w","article-title":"Cyclophosphamide in the treatment of systemic lupus erythematosus-related Guillain-Barr\u00e9 syndrome: a systematic review of case reports","volume":"18","author":"Xiong A","year":"2023","unstructured":"Xiong A, Cui H, Deng R, Wei X. Cyclophosphamide in the treatment of systemic lupus erythematosus-related Guillain-Barr\u00e9 syndrome: a systematic review of case reports. J Neuroimmune Pharmacol. 2023, 18:285-93. 10.1007\/s11481-023-10075-w","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref17","article-title":"Posterior Reversible Encephalopathy Syndrome","author":"Zelaya JE","year":"2022","unstructured":"Zelaya JE, Al-Khoury L. Posterior Reversible Encephalopathy Syndrome. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref18","article-title":"Progressive Multifocal Leukoencephalopathy","author":"Saji AM","year":"2023","unstructured":"Saji AM, Gupta V. Progressive Multifocal Leukoencephalopathy. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17969","article-title":"Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges","volume":"13","author":"Sarwar S","year":"2021","unstructured":"Sarwar S, Mohamed AS, Rogers S, et al.. Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges. Cureus. 2021, 13:e17969. 10.7759\/cureus.17969","journal-title":"Cureus"},{"key":"ref20","article-title":"Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion?","volume":"12","author":"Monov S","year":"2008","unstructured":"Monov S, Monova D. Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion?. Hippokratia. 2008, 12:103-7.","journal-title":"Hippokratia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead685","article-title":"Attribution of neuropsychiatric symptoms and prioritisation of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study","author":"Sloan M","year":"2023","unstructured":"Sloan M, Andreoli L, Zandi MS, et al.. Attribution of neuropsychiatric symptoms and prioritisation of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study. Rheumatology (Oxford). 2023, kead685. 10.1093\/rheumatology\/kead685","journal-title":"Rheumatology (Oxford)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab324","article-title":"Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review","volume":"61","author":"Silvagni E","year":"2021","unstructured":"Silvagni E, Chessa E, Bergossi F, et al.. Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review. Rheumatology (Oxford). 2021, 61:8-23. 10.1093\/rheumatology\/keab324","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/247261-neuropsychiatric-systemic-lupus-erythematosus-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T19:40:51Z","timestamp":1717530051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/247261-neuropsychiatric-systemic-lupus-erythematosus-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.61678","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,4]]}}}